What is Medtronic's D&A?

Medtronic (MDT) reported D&A of $716M in Q1 2026.

How has Medtronic's D&A changed year-over-year?

Medtronic's D&A decreased by 14.8% year-over-year, from $840M to $716M.

What is the long-term trend for Medtronic's D&A?

Over 4 years (2022 to 2026), Medtronic's D&A has grown at a 2.2% compound annual growth rate (CAGR), from $2.71B to $2.96B.

Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.

Medtronic MDT D&A

D&A at other companies

TFX

TeleflexTFX

$53.74M+39.2%

ArtivionAORT

$6.34M+16.4%

CONMEDCNMD

$8.7M0.0%

Merit Medical SystemsMMSI

$30.5M+4.1%

DexComDXCM

——

InsuletPODD

——

Segments

By segment

See full

Neuroscience$85M+18.1%

Cardiovascular$67M+15.5%

Medical Surgical$56M+5.7%

Diabetes$32M+6.7%

Other operating segment$0—

Other financials

Income statement

See full

Revenue$9.8B+9.9%

Gross profit$6.4B+10.9%

Operating income$1.9B+30.4%

Net income$1.2B+17.8%

EPS (diluted)$0.97+18.3%

Balance sheet

See full

Cash & equivalents$1.9B-12.1%

Total debt$29.2B-1.6%

Total equity$49.5B+3.0%

Total assets$93.0B+1.5%

Cash flow

See full

Operating cash flow$2.6B+1.8%

CapEx$488.0M+6.3%

Free cash flow$2.1B+0.8%

Valuation

See full

Market cap$103.66B-6.0%

Enterprise value$130.92B-5.0%

P/E21.6×-2.1×

P/S2.9×-0.4×

Profitability

See full

Gross margin65%-0.3pp

Operating margin17.8%0.0pp

Net margin13.2%-0.7pp

FCF margin14.9%-0.5pp

Returns & leverage

See full

Return on equity9.8%+0.4pp

Debt / equity0.6×0.0×

Current ratio2.1×+0.3×

Where this comes from

Reported directly by Medtronic in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: Medtronic’s 10-K, filed June 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medtronic's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Medtronic's D&A?: Medtronic (MDT) reported D&A of $716M in Q1 2026.
How has Medtronic's D&A changed year-over-year?: Medtronic's D&A decreased by 14.8% year-over-year, from $840M to $716M.
What is the long-term trend for Medtronic's D&A?: Over 4 years (2022 to 2026), Medtronic's D&A has grown at a 2.2% compound annual growth rate (CAGR), from $2.71B to $2.96B.
What does D&A mean?: Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.